Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2012 4
2013 8
2014 12
2015 12
2016 9
2017 19
2018 14
2019 14
2020 17
2021 21
2022 14
2023 16
2024 26
2025 26

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

179 results

Results by year

Filters applied: . Clear all
Page 1
Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer.
Heidegger I, Fotakis G, Offermann A, Goveia J, Daum S, Salcher S, Noureen A, Timmer-Bosscha H, Schäfer G, Walenkamp A, Perner S, Beatovic A, Moisse M, Plattner C, Krogsdam A, Haybaeck J, Sopper S, Thaler S, Keller MA, Klocker H, Trajanoski Z, Wolf D, Pircher A. Heidegger I, et al. Mol Cancer. 2022 Jun 18;21(1):132. doi: 10.1186/s12943-022-01597-7. Mol Cancer. 2022. PMID: 35717322 Free PMC article.
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway.
Pencik J, Philippe C, Schlederer M, Atas E, Pecoraro M, Grund-Gröschke S, Li WJ, Tracz A, Heidegger I, Lagger S, Trachtová K, Oberhuber M, Heitzer E, Aksoy O, Neubauer HA, Wingelhofer B, Orlova A, Witzeneder N, Dillinger T, Redl E, Greiner G, D'Andrea D, Östman JR, Tangermann S, Hermanova I, Schäfer G, Sternberg F, Pohl EE, Sternberg C, Varady A, Horvath J, Stoiber D, Malcolm TI, Turner SD, Parkes EE, Hantusch B, Egger G, Rose-John S, Poli V, Jain S, Armstrong CWD, Hoermann G, Goffin V, Aberger F, Moriggl R, Carracedo A, McKinney C, Kennedy RD, Klocker H, Speicher MR, Tang DG, Moazzami AA, Heery DM, Hacker M, Kenner L. Pencik J, et al. Among authors: heidegger i. Mol Cancer. 2023 Aug 12;22(1):133. doi: 10.1186/s12943-023-01825-8. Mol Cancer. 2023. PMID: 37573301 Free PMC article.
Reply by Authors.
Marra G, Barletta F, Scuderi S, Montefusco G, Olivier J, Affentranger A, Grogg JB, Hermanns T, Afferi L, Fankhauser C, Mattei A, Malkiewicz B, Bianchi A, Antonelli A, Zattoni F, Dal Moro F, Wever L, Soeterik TFW, Van Den Bergh RCN, Rajwa P, Shariat SF, Sanchez-Salas R, Rodriguez-Sanchez L, Nicoletti R, Campi R, Ahmed M, Karnes RJ, Heidegger I, Briganti A, Montorsi F, Gontero P, Gandaglia G. Marra G, et al. Among authors: heidegger i. J Urol. 2025 Jun;213(6):711-712. doi: 10.1097/JU.0000000000004534. Epub 2025 Apr 8. J Urol. 2025. PMID: 40197015 No abstract available.
Drug-Drug Interactions in Prostate Cancer Treatment.
Hebenstreit D, Pichler R, Heidegger I. Hebenstreit D, et al. Among authors: heidegger i. Clin Genitourin Cancer. 2020 Apr;18(2):e71-e82. doi: 10.1016/j.clgc.2019.05.016. Epub 2019 May 27. Clin Genitourin Cancer. 2020. PMID: 31677899 Review.
The anti-diabetic PPARγ agonist Pioglitazone inhibits cell proliferation and induces metabolic reprogramming in prostate cancer.
Atas E, Berchtold K, Schlederer M, Prodinger S, Sternberg F, Pucci P, Steel C, Matthews JD, James ER, Philippe C, Trachtová K, Moazzami AA, Artamonova N, Melchior F, Redmer T, Timelthaler G, Pohl EE, Turner SD, Heidegger I, Krueger M, Resch U, Kenner L. Atas E, et al. Among authors: heidegger i. Mol Cancer. 2025 May 5;24(1):134. doi: 10.1186/s12943-025-02320-y. Mol Cancer. 2025. PMID: 40320521 Free PMC article.
Intravenous iron-induced hypophosphatemia and kidney stone disease.
Panzer M, Meindl E, Schaefer B, Wagner S, Glodny B, Mayer G, Pircher A, Schwarz C, Beckmann F, Hejny C, Joachim-Mrosko B, Konzett J, Tilg H, Heidegger I, Wolf M, Weiskirchen R, Zoller H. Panzer M, et al. Among authors: heidegger i. Bone Rep. 2024 Mar 29;21:101759. doi: 10.1016/j.bonr.2024.101759. eCollection 2024 Jun. Bone Rep. 2024. PMID: 38590391 Free PMC article.
Safety and Efficacy of 177Lu-PSMA Therapy Following 223Radium Treatment: A Retrospective Multinational Real-World Analysis.
Giannini G, Kafka M, Neuwirt H, Artamonova N, Santo GD, Virgolini I, Dotzauer R, Deiss E, Paffenholz P, Heidenreich A, Rasul S, Tsaur I, Rausch S, Einspieler H, la Fougère C, Trautwein NF, Zattoni F, Sepulcri M, Heidegger I. Giannini G, et al. Among authors: heidegger i. Clin Genitourin Cancer. 2025 Feb;23(1):102260. doi: 10.1016/j.clgc.2024.102260. Epub 2024 Nov 1. Clin Genitourin Cancer. 2025. PMID: 39608079
179 results